نتایج جستجو برای: limited cutaneous scleroderma

تعداد نتایج: 485654  

2012
Christopher P Denton Thomas Krieg Loic Guillevin Barbara Schwierin Daniel Rosenberg Mariabeth Silkey Maurice Zultak Marco Matucci-Cerinic

OBJECTIVES The Digital Ulcers Outcome (DUO) Registry was designed to describe the clinical and antibody characteristics, disease course and outcomes of patients with digital ulcers associated with systemic sclerosis (SSc). METHODS The DUO Registry is a European, prospective, multicentre, observational, registry of SSc patients with ongoing digital ulcer disease, irrespective of treatment regi...

Journal: :Annals of the rheumatic diseases 2007
U A Walker A Tyndall L Czirják C Denton D Farge-Bancel O Kowal-Bielecka U Müller-Ladner C Bocelli-Tyndall M Matucci-Cerinic

BACKGROUND Systemic sclerosis (SSc) is a multisystem autoimmune disease, which is classified into a diffuse cutaneous (dcSSc) and a limited cutaneous (lcSSc) subset according to the skin involvement. In order to better understand the vascular, immunological and fibrotic processes of SSc and to guide its treatment, the EULAR Scleroderma Trials And Research (EUSTAR) group was formed in June 2004....

Journal: :The Yale Journal of Biology and Medicine 1994
Karen Broder Eric Reinhardt Richard Lifton William Tamborlane Barbara Pober

Because the current assessment of scleroderma skin through clinical skin scoring is subjective and imprecise, we investigated fully quantitative, physical measures of cutaneous involvement in the disease. First, we developed image analysis software for calculating the dermal density of colla-gen from 58 scleroderma and 327 control biopsies scanned onto our computer. Second, using a durometer ga...

Journal: :Arthritis Research & Therapy 2009
Nicolas Hunzelmann Pia Moinzadeh Ekkehard Genth Thomas Krieg Walter Lehmacher Inga Melchers Michael Meurer Ulf Müller-Ladner Thorsten M Olski Christiane Pfeiffer Gabriela Riemekasten Eckhard Schulze-Lohoff Cord Sunderkoetter Manfred Weber

INTRODUCTION In systemic sclerosis (SSc) little evidence for the effectiveness of anti-inflammatory and immunosuppressive therapy exists. The objective of this study was to determine the extent to which SSc patients are treated with corticosteroids and immunosuppressive agents. METHODS Data on duration and dosage of corticosteroids and on the type of immunosuppressive agent were analyzed from...

Journal: :The European respiratory journal 2006
M C Tamby M Humbert P Guilpain A Servettaz N Dupin J J Christner G Simonneau J Fermanian B Weill L Guillevin L Mouthon

The aim of the present study was to investigate the presence of anti-fibroblast antibodies in patients with idiopathic or scleroderma-associated pulmonary arterial hypertension (PAH) and healthy controls. PAH was documented by right-heart catheterisation (mean pulmonary artery pressure at rest >25 mmHg). Serum immunoglobulin (Ig)G and IgM reactivities of patients with idiopathic PAH (n = 35), s...

2008
Shangxi Liu Mohit Kapoor Xu Shi-wen Laura Kennedy Christopher P. Denton David J. Abraham Andrew Leask

1 Division of Oral Biology, University of Western Ontario, London, ON, Canada 2 Centre for Rheumatology, University College London (Royal Free Campus), UK Background Activated adhesive signaling is a hallmark of fibroblasts isolated from scars of scleroderma (systemic sclerosis; SSc) lesions. Rac1 plays a key role in adhesive signaling. The aim of the present study was to examine the role of Ra...

2013
Allan C. Gelber Rebecca L. Manno Ami A. Shah Adrianne Woods Elizabeth N. Le Francesco Boin Laura K. Hummers Fredrick M. Wigley

Experience suggests that African Americans may express autoimmune disease differently than other racial groups. In the context of systemic sclerosis (scleroderma), we sought to determine whether race was related to a more adverse expression of disease. Between January 1, 1990, and December 31, 2009, a total of 409 African American and 1808 white patients with scleroderma were evaluated at a sin...

2016
Muhammad W Saif Archana Agarwal James Hellinger Dorothy J Park Elizabeth Volkmann

Drug-induced scleroderma is a rare adverse effect of some chemotherapeutic drugs, such as taxanes and bleomycin. Capecitabine, an oral fluoropyrimidine approved for the treatment of metastatic breast and colon cancer, commonly causes cutaneous side effects including the hand-and-foot syndrome (HFS). Scleroderma-like skin changes associated with HFS associated with capecitabine is rare. However,...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید